Delaware's largest orthopaedic group practice, offering platelet-rich plasma, bone marrow and fat-derived cell injections alongside conventional orthopaedic surgery.
First State Orthopaedics, which now trades as part of OrthoDelaware, is a large orthopaedic group practice in Delaware. It was formed in 2018 through a merger and describes itself as the state's first Delaware-based orthopaedic supergroup. The group runs eight physician offices, three imaging centres, two surgery centres and four physical therapy locations across the state.
Cell-based and orthobiologic injections are offered as one option within a full orthopaedic service that also includes joint replacement, spine surgery, trauma care, sports medicine, imaging, pain management and rehabilitation. The site presents these injections as an alternative to repeated corticosteroid injections or to surgery. Because this is a mainstream orthopaedic group rather than a standalone stem cell clinic, a patient would normally be assessed by an orthopaedic surgeon first and offered the full range of options.
The site names several biologic materials, including platelet-rich plasma (PRP) from the patient's own blood, bone marrow aspirate, fat aspiration, amniotic fluid or tissue products, and cells described as coming from donor bone. Products derived from amniotic tissue or donor bone are regulated differently from a patient's own tissue in the United States, so it is worth asking exactly which product would be used in your case and what its regulatory status is.
The site lists body areas and surgical specialties rather than a named condition list, so ask what specific diagnosis an injection is being proposed for and what evidence supports it.
The site names both the patient's own tissue and donor-derived products.
The group operates eight physician offices across Delaware, at Dover, Brandywine, the Medical Arts Pavilion, Middletown, Milford, Pike Creek, Newark (Sabre) and Smyrna, together with three imaging centres, two surgery centres and four physical therapy locations. The main telephone number given is (302) 731-2888. The group dates from a 2018 merger. The website offers machine translation into many languages, but no interpreter service or dedicated international patient programme is described.
No prices for orthobiologic or cell-based injections are published on this page. As a mainstream orthopaedic group, much of its care is billed to insurance, but biologic injections often are not — ask specifically what will and will not be covered.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.